Clinical trials
Parkinson Disease trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
167 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 12 |
| 2019 | 13 |
| 2020 | 6 |
| 2021 | 12 |
| 2022 | 12 |
| 2023 | 21 |
| 2024 | 19 |
| 2025 | 33 |
| 2026 | 28 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
| Recruiting | 38 |
| Unknown status | 19 |
| Enrolling by invitation | 5 |
| Active, not recruiting | 5 |
| Not yet recruiting | 4 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gazi University | 18 |
| Hacettepe University | 10 |
| Abant Izzet Baysal University | 6 |
| Ankara University | 6 |
| Acibadem University | 5 |
| Istanbul Medipol University Hospital | 5 |
| Emre Şenocak | 4 |
| Istanbul University | 4 |
| Kahramanmaras Sutcu Imam University | 4 |
| Marmara University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 167 |
| Fatigue | 5 |
| Gait Disorders, Neurologic | 5 |
| Tremor | 4 |
| Dyskinesias | 3 |
| Inflammation | 3 |
| Multiple Sclerosis | 3 |
| Nervous System Diseases | 3 |
| Sarcopenia | 3 |
| Stroke | 3 |
Trials
Showing 1 to 25 of 167. Each trial links to its page on Pharma Observatory.
67 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.